AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2012
May 4, 2012
284_dirs_2012-05-04_c1b26fc5-378d-45e8-974d-e500961f306f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2012-05-02
Reporting Person: Heller Bridgette P (Exe.VP & Pres.Con.Hlth.Care)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-02 | Restricted Stock Unit | $ | A | 5599.0000 | Acquired | 2015-05-02 | Common Stock (5599.0000) | Direct |
| 2012-05-02 | Stock Option (right to buy) | $39.2900 | A | 80439.0000 | Acquired | 2022-05-01 | Common Stock (80439.0000) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2: The option vests in three equal annual installments beginning May 2, 2013.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30